Zevra Therapeutics (ZVRA) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Zevra Therapeutics (ZVRA) over the last 9 years, with Q3 2025 value amounting to 0.32.
- Zevra Therapeutics' Asset Utilization Ratio rose 11995.09% to 0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32, marking a year-over-year increase of 11995.09%. This contributed to the annual value of 0.13 for FY2024, which is 2942.1% down from last year.
- Per Zevra Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.32 for Q3 2025, which was up 11995.09% from 0.29 recorded in Q2 2025.
- Zevra Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.46 during Q1 2021, with a 5-year trough of 0.08 in Q2 2022.
- Its 5-year average for Asset Utilization Ratio is 0.19, with a median of 0.16 in 2024.
- In the last 5 years, Zevra Therapeutics' Asset Utilization Ratio tumbled by 8796.68% in 2021 and then surged by 11995.09% in 2025.
- Over the past 5 years, Zevra Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.21 in 2021, then plummeted by 59.21% to 0.09 in 2022, then surged by 103.92% to 0.18 in 2023, then dropped by 27.67% to 0.13 in 2024, then soared by 151.34% to 0.32 in 2025.
- Its Asset Utilization Ratio stands at 0.32 for Q3 2025, versus 0.29 for Q2 2025 and 0.23 for Q1 2025.